Screener
ClearPoint Neuro CLPT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value; 25,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value; 90,000,000 shares authorized at March 31, 2026 and December 31, 2025; 29,986,639 and 29,368,760 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 300 | 294 |
| Additional paid-in capital | 239,468 | 238,995 |
| Shares to be issued | 5,535 | 5,641 |
| Accumulated deficit | (226,462) | (216,910) |
| Total stockholders’ equity | 18,841 | 28,020 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's common stock?
- ClearPoint Neuro (CLPT) reported common stock of 90M in Q1 2026.
- How has ClearPoint Neuro's common stock changed year-over-year?
- ClearPoint Neuro's common stock decreased by 0.0% year-over-year, from 90M to 90M.
- What is the long-term trend for ClearPoint Neuro's common stock?
- Over 5 years (2020 to 2025), ClearPoint Neuro's common stock has grown at a 250.6% compound annual growth rate (CAGR), from 170K to 90M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about ClearPoint Neuro's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude